Lowe Brockenbrough & Co. Inc. reduced its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 27.1% during the first quarter, Holdings Channel reports. The firm owned 10,443 shares of the company’s stock after selling 3,874 shares during the period. Lowe Brockenbrough & Co. Inc.’s holdings in Express Scripts Holding were worth $688,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in ESRX. Old Mutual Global Investors UK Ltd. raised its position in shares of Express Scripts Holding by 311.4% in the first quarter. Old Mutual Global Investors UK Ltd. now owns 2,157,210 shares of the company’s stock valued at $142,181,000 after buying an additional 1,632,801 shares during the period. Renaissance Technologies LLC raised its position in shares of Express Scripts Holding by 9,353.3% in the first quarter. Renaissance Technologies LLC now owns 1,308,239 shares of the company’s stock valued at $86,226,000 after buying an additional 1,294,400 shares during the period. Ameriprise Financial Inc. raised its position in shares of Express Scripts Holding by 17.2% in the first quarter. Ameriprise Financial Inc. now owns 5,028,552 shares of the company’s stock valued at $331,430,000 after buying an additional 736,151 shares during the period. Barrow Hanley Mewhinney & Strauss LLC raised its position in shares of Express Scripts Holding by 4.2% in the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 17,612,834 shares of the company’s stock valued at $1,160,862,000 after buying an additional 704,218 shares during the period. Finally, Vanguard Group Inc. raised its position in shares of Express Scripts Holding by 1.6% in the first quarter. Vanguard Group Inc. now owns 40,251,311 shares of the company’s stock valued at $2,652,964,000 after buying an additional 649,400 shares during the period. 90.20% of the stock is owned by institutional investors.

Shares of Express Scripts Holding Company (NASDAQ ESRX) traded up 0.86% during midday trading on Friday, reaching $60.82. 2,898,864 shares of the company’s stock traded hands. The stock has a 50 day moving average of $62.73 and a 200-day moving average of $64.48. Express Scripts Holding Company has a 12 month low of $57.80 and a 12 month high of $77.61. The stock has a market cap of $35.13 billion, a P/E ratio of 10.56 and a beta of 0.90.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.02. The firm had revenue of $25.35 billion during the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The business’s revenue was up .5% on a year-over-year basis. During the same period last year, the company earned $1.57 earnings per share. On average, equities research analysts forecast that Express Scripts Holding Company will post $6.99 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Express Scripts Holding Company (ESRX) Shares Sold by Lowe Brockenbrough & Co. Inc.” was originally reported by Daily Political and is the property of of Daily Political. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://www.dailypolitical.com/2017/08/13/express-scripts-holding-company-esrx-shares-sold-by-lowe-brockenbrough-co-inc.html.

ESRX has been the subject of several research analyst reports. Robert W. Baird decreased their price target on shares of Express Scripts Holding from $73.00 to $53.00 and set a “neutral” rating for the company in a report on Tuesday, April 25th. Morgan Stanley decreased their price target on shares of Express Scripts Holding from $71.00 to $52.00 and set an “underweight” rating for the company in a report on Wednesday, April 26th. SunTrust Banks, Inc. reaffirmed a “buy” rating on shares of Express Scripts Holding in a research note on Tuesday, April 25th. Cowen and Company reduced their target price on shares of Express Scripts Holding from $90.00 to $83.00 and set an “outperform” rating for the company in a research note on Tuesday, April 25th. Finally, Edward Jones lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Wednesday, April 26th. Four investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Express Scripts Holding currently has an average rating of “Hold” and an average price target of $71.17.

In other news, VP Phyllis S. Anderson sold 1,100 shares of Express Scripts Holding stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $60.08, for a total transaction of $66,088.00. Following the completion of the transaction, the vice president now directly owns 11,108 shares in the company, valued at $667,368.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.68% of the stock is owned by company insiders.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.